[1] 黄锐,姚立正,李文会, 等. 肝动脉化疗栓塞术联合甲磺酸阿帕替尼片治疗中晚期肝癌的疗效及安全性评价[J]. 肿瘤, 2018,38(10):965-972. Huang R,Yao L Z, Li W H, et al. Efficacy and safety of TACE combined with apatinib mesylate tablets in the treatment of intermediate and advanced hepatoma[J]. Tumor, 2018,38(10):965-972.
[2] Wang H, Shu S, Li J, et al. Management of liver cancer argon-helium knife therapy with functional computer tomography perfusion imaging[J]. Cancer Treatment and Research, 2016,15(1):29-35.
[3] 中华人民共和国国家卫生和计划生育委员会医政医管局. 原发性肝癌诊疗规范(2017年版)[J]. 中华消化外科杂志, 2017,16(7):635-647. Medical Administration Bureau of the Health and Family Planning Commission, People's Republic of China. Diagnosis, management, and treatment of hepatocellular carcinoma(2017)[J]. Chinese Journal of Hepatology, 2017,16(7):635-647.
[4] Eisenhauerae A,Therasseb P,Bogaerts J,et al.New response evaluation criteria in solid tumours:revised RECIST guideline(version 1.1)[J]. European Journal of Cancer, 2009, (45):228-247.
[5] 梁长华, 毛华杰, 岳军艳, 等. 肝细胞肝癌CT全肿瘤灌注测量值与MVD及其与病理分化程度的相关性[J]. 实用癌症杂志, 2017,32(9):1401-1405. Liang C H, Mao H J, Yue J Y, et al. A preliminary study of the total tumor perfusion by volume CT perfusion imaging in evaluating angiogenesis and their relationships with the pathological grading[J]. The Practical Journal of Cancer, 2017,32(9):1401-1405.
[6] Philipp L R, McCracken D J, McCracken C E, et al. Compa-rison between CTA and digital subtraction angiography in the diagnosis of ruptured aneurysms[J]. Neurosurgery, 2017,80(5):769-777.
[7] 刘洋, 寻航, 李修奎, 等. 螺旋CT灌注成像与超声超微细血流成像在评估肝癌介入术后活性病灶血供中的应用比较[J]. 中国CT与MRI杂志, 2019,17(4):86-88. Lie Y, Xun H, Li X K, et al. Application of spiral CT perfusion imaging and superb microvascular imaging in evaluating blood supply of active lesions after interventional operation for liver cancer[J]. Chinese Journal of CT and MRI, 2019,17(4):86-88.
[8] 刘月军, 刘向东. 双源螺旋CT多时相灌注成像在诊断原发性小肝癌中的价值研究[J]. 肝脏, 2017,22(4):373-374. Liu Y J, Liu X D. The value of multi-phase perfusion imaging with dual source spiral CT in the diagnosis of primary small liver cancer[J]. Chinese Hepatology, 2017,22(4):373-374.
[9] Du F, Jiang R, Gu M, et al. The clinical application of 320-detector row CT in transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma[J]. La Radiologia Medica, 2015,120(8):690-694.
[10] Chen C S, Li F K, Guo C Y, et al. Tumor vascularity and lipiodol deposition as early radiological markers for predicting risk of disease progression in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization[J]. Oncotarget, 2016,7(6):7241-7252.
[11] 何二霞, 聂忠仕, 朱明月, 等. CT灌注成像结合全肝增强扫描对41例中晚期肝癌患者行TACE疗效的评价[J]. 临床放射学杂志, 2013,32(12):1734-1738. He E X, Nie Z S, Zhu M Y, et al. CT perfusion imaging combined with whole liver enhancement scanned in evaluating curative effect of 41 patients harbor mid advanced stage liver cancer after TACE[J]. Journal of Clinical Radiology, 2013,32(12):1734-1738.
[12] Kim M N, Kim B K, Han K H, et al. Evolution from WHO to EASL and mRECIST for hepatocellular carcinoma:consi-derations for tumor response assessment[J]. Expert Review of Gastroenterology and Hepatology, 2015,9(3):335-348.
[13] Zhou Y, Gao J B, Xu H, et al. Evaluation of neovascularization with spectral computed tomography in a rabbit VX2 liver model:a comparison with real-time contrast-enhanced ultrasound and molecular biological findings[J]. British Journal of Radiology, 2015,88(1055):20140548.
[14] Feng Y, Zu L L, Zhang L. MicroRNA-26b inhibits the tumor growth of human liver cancer through the PI3K/Akt and NF-κB/MMP-9/VEGF pathways[J]. Oncology Reports, 2018,39(5):2288-2296.
[15] 方蕾, 赵展, 吴乾能, 等. 恩度联合TACE术治疗肝癌对患者血清VEGF、HIF-1A、OPN、MMP-9的影响及意义[J]. 中华全科医学, 2016,14(3):412-414. Fang L, Zhao Z, Wu Q N, et al. Influence and significance of hepatic transcatheter arterial chemoembolization combime with endostar on levels of serum VEGF, HIF-1A, OPN and MMP-9 in patients with hepatocellular carcinoma[J]. Chinese Journal of General Practice, 2016,14(3):412-414.
[16] 谢青云, 雷泽华, 高峰畏, 等. 肝癌TACE介入治疗前后血清AFP、AKP、γ-GT水平的变化[J]. 昆明医科大学学报, 2018,39(10):101-104. Xie Q Y, Lei Z H, Gao F W, et al. Changes and clinical significance of serum AFP, AKP and γ-GT levels in patients with primary liver cancer before and after TACE interventional therapy[J]. Journal of Kunming Medical University, 2018,39(10):101-104. |